首页 > 最新文献

European Neurology最新文献

英文 中文
Effects and Safety of Monoamine Oxidase-B Inhibitors for Early Parkinson's Disease: A Network Meta-Analysis. 单胺氧化酶-B 抑制剂治疗早期帕金森病的效果和安全性:网络荟萃分析。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-09-14 DOI: 10.1159/000541315
Yaping Wang, Zhiyun Wang

Introduction: The objective of this study was to evaluate the effects and safety of monoamine oxidase-B inhibitors (MAO-B inhibitors) for early Parkinson's disease (PD).

Methods: All studies that assessed the efficacy of MAO-B inhibitors in patients with early PD were searched. Publications were screened, and data were extracted according to predefined criteria. Rev Man 5.4 and Stata 14.0 software were used for statistical analysis. Outcomes assessed included change of Unified Parkinson's Disease Rating Scale (UPDRS) total score, UPDRS part II score, UPDRS part III score, and the incidence of adverse events.

Results: Thirty trials were identified and included in this meta-analysis. Compared with placebo, rasagiline, selegiline, safinamide, and zonisamide were significantly more effective, with a standardized mean difference (SMD) of -0.41 (95% confidence interval (CI) = -0.64 to -0.18), SMD = -0.38 (95% CI = -0.51 to -0.24), SMD = -0.37 (95% CI = -0.54 to -0.21), and SMD = -0.31 (95% CI = -0.57 to -0.05) on the UPDRS III score change, respectively. The surface under the cumulative ranking results showed that rasagiline ranked first in improving UPDRS II and UPDRS III, respectively. For safety outcomes, safinamide combination with dopaminergic treatment had lower risk of incurring any adverse events (risk ratio = 0.1, 95% CI = 0.01-0.2), and no statistical difference in incidence of adverse events was observed among other MAO-B inhibitor regimes and placebo.

Conclusion: Rasagiline, selegiline, safinamide, and zonisamide were effective compared to placebo in the treatment of early PD, but rasagiline was the most effective drug. As for safety, safinamide combination with dopaminergic treatment had lower risk of incurring any adverse events.

简介:评估单胺氧化酶 B 抑制剂(MAO-B 抑制剂)治疗早期帕金森病的效果和安全性:评估单胺氧化酶 B 抑制剂(MAO-B 抑制剂)治疗早期帕金森病的效果和安全性:方法:检索所有评估MAO-B抑制剂对早期帕金森病患者疗效的研究。按照预先确定的标准筛选文献并提取数据。使用Rev Man 5.4和Stata 14.0软件进行统计分析。评估的结果包括统一帕金森病评分量表(UPDRS)总分、UPDRS第二部分评分、UPDRS第三部分评分的变化以及不良事件的发生率:本次荟萃分析共确定并纳入了 30 项试验。与安慰剂相比,拉沙吉林、西格列汀、沙芬那胺和唑尼沙胺的疗效显著,其UPDRS III评分变化的标准化平均差(SMD)分别为-0.41(95%置信区间(CI)=-0.64至-0.18)、SMD=-0.38(95%CI=-0.51至-0.24)、SMD=-0.37(95%CI=-0.54至-0.21)和SMD=-0.31(95%CI=-0.57至-0.05)。表面累积排名(SUCRA)结果显示,在改善UPDRS II和UPDRS III方面,拉沙吉林分别排名第一。在安全性方面,沙芬那胺联合多巴胺能治疗发生任何不良事件的风险较低(风险比=0.1 95% CI=0.01至0.2),其他MAO-B抑制剂方案和安慰剂在不良事件发生率方面没有统计学差异:总之,与安慰剂相比,拉沙吉兰、西格列汀、沙芬酰胺和唑尼沙胺对治疗早期帕金森病有效,但拉沙吉兰是最有效的药物。在安全性方面,沙芬胺联合多巴胺能治疗发生不良反应的风险较低。
{"title":"Effects and Safety of Monoamine Oxidase-B Inhibitors for Early Parkinson's Disease: A Network Meta-Analysis.","authors":"Yaping Wang, Zhiyun Wang","doi":"10.1159/000541315","DOIUrl":"10.1159/000541315","url":null,"abstract":"<p><strong>Introduction: </strong>The objective of this study was to evaluate the effects and safety of monoamine oxidase-B inhibitors (MAO-B inhibitors) for early Parkinson's disease (PD).</p><p><strong>Methods: </strong>All studies that assessed the efficacy of MAO-B inhibitors in patients with early PD were searched. Publications were screened, and data were extracted according to predefined criteria. Rev Man 5.4 and Stata 14.0 software were used for statistical analysis. Outcomes assessed included change of Unified Parkinson's Disease Rating Scale (UPDRS) total score, UPDRS part II score, UPDRS part III score, and the incidence of adverse events.</p><p><strong>Results: </strong>Thirty trials were identified and included in this meta-analysis. Compared with placebo, rasagiline, selegiline, safinamide, and zonisamide were significantly more effective, with a standardized mean difference (SMD) of -0.41 (95% confidence interval (CI) = -0.64 to -0.18), SMD = -0.38 (95% CI = -0.51 to -0.24), SMD = -0.37 (95% CI = -0.54 to -0.21), and SMD = -0.31 (95% CI = -0.57 to -0.05) on the UPDRS III score change, respectively. The surface under the cumulative ranking results showed that rasagiline ranked first in improving UPDRS II and UPDRS III, respectively. For safety outcomes, safinamide combination with dopaminergic treatment had lower risk of incurring any adverse events (risk ratio = 0.1, 95% CI = 0.01-0.2), and no statistical difference in incidence of adverse events was observed among other MAO-B inhibitor regimes and placebo.</p><p><strong>Conclusion: </strong>Rasagiline, selegiline, safinamide, and zonisamide were effective compared to placebo in the treatment of early PD, but rasagiline was the most effective drug. As for safety, safinamide combination with dopaminergic treatment had lower risk of incurring any adverse events.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"273-290"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemorrhagic Stroke as Inspiration for Poetry: The Case of Alfred Tennyson, Arthur Henry Hallam, and In Memoriam A.H.H. 出血性中风作为诗歌的灵感:阿尔弗雷德·丁尼生、阿瑟·亨利·哈勒姆和纪念A.H.H.的案例
IF 2.4 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2023-11-21 DOI: 10.1159/000535327
Matheus Pedro

Background: Neurology and literature have a complex interface; one of the facets is that of works inspired by grief on the passing of a beloved one due to a neurological disease.

Summary: In Memoriam A.H.H., written by Alfred Tennyson and published in 1850 in response to the untimely death of Arthur Henry Hallam, is one such elegy, which had a profound impact in Tennyson's body of work and on the history of Victorian poetry in general. In this review, the author delineates biographical notes of both men before analyzing the disease and death of Arthur Hallam due to hemorrhagic stroke.

Key messages: By evaluating Hallam's autopsy report and contemplating the different hypotheses on the etiology of his stroke, as well as how his death due to catastrophic neurological disease was memorialized in verse, neurologists may gain better insight on the interface between neurology and literature inspired by grief.

背景:摘要:《悼念A.H.H.》(In Memoriam A.H.H.)由阿尔弗雷德-丁尼生(Alfred Tennyson)撰写,发表于1850年,以回应亚瑟-亨利-哈勒姆(Arthur Henry Hallam)的早逝,就是这样一首挽歌,对丁尼生的作品乃至整个维多利亚诗歌史产生了深远影响。在这篇评论中,作者在分析阿瑟-哈勒姆因出血性中风而导致的疾病和死亡之前,详细介绍了两人的生平简介:通过评估哈兰的尸检报告,思考关于其中风病因的不同假设,以及如何用诗歌纪念他因灾难性神经疾病而死,神经病学家可以更好地洞察神经病学与因悲伤而激发的文学之间的关系。
{"title":"Hemorrhagic Stroke as Inspiration for Poetry: The Case of Alfred Tennyson, Arthur Henry Hallam, and In Memoriam A.H.H.","authors":"Matheus Pedro","doi":"10.1159/000535327","DOIUrl":"10.1159/000535327","url":null,"abstract":"<p><strong>Background: </strong>Neurology and literature have a complex interface; one of the facets is that of works inspired by grief on the passing of a beloved one due to a neurological disease.</p><p><strong>Summary: </strong>In Memoriam A.H.H., written by Alfred Tennyson and published in 1850 in response to the untimely death of Arthur Henry Hallam, is one such elegy, which had a profound impact in Tennyson's body of work and on the history of Victorian poetry in general. In this review, the author delineates biographical notes of both men before analyzing the disease and death of Arthur Hallam due to hemorrhagic stroke.</p><p><strong>Key messages: </strong>By evaluating Hallam's autopsy report and contemplating the different hypotheses on the etiology of his stroke, as well as how his death due to catastrophic neurological disease was memorialized in verse, neurologists may gain better insight on the interface between neurology and literature inspired by grief.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"43-48"},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138290766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of Life in Patients with Excellent 3-Month Clinical Outcome after First-Ever Ischemic Stroke: A Time to Redefine Excellent Outcome? 首次发生缺血性卒中后三个月临床疗效极佳的患者的生活质量:是时候重新定义优秀预后了吗?
IF 2.4 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-01-17 DOI: 10.1159/000535685
Daniel Šaňák, Elena Gurková, Lenka Štureková, Šárka Šaňáková, Jana Zapletalová, David Franc, Daniela Bartoníčková

Introduction: Ischemic stroke (IS) may have impact on long-term health-related quality of life (HRQoL) even in the patients with good clinical outcome, and tools mostly used for the assessment of outcome may underestimate or not reflect all relevant sequels after IS. We aimed to analyze HRQoL in the patients with excellent outcome after IS.

Methods: We analyzed consecutive IS patients enrolled in the prospective FRAILTY study (ClinicalTrials.gov: NCT04839887) with excellent 3-month clinical outcome (score 0-1 in modified Rankin Scale [mRS]). Stroke Impact Scale (SIS) version 3.0 and Hospital Anxiety and Depression Scale (HADS) were used for the HRQoL, anxiety, and depression assessments, and subgroup comparisons were performed according to NIHSS score (0, ≥1), age (50<, ≥50 years), and sex.

Results: In total, 158 patients (55.7% men, mean age 60.3 ± 13.4 years) were analyzed, and 72.2% of them had score 0 in mRS. The overall lowest median scores were found in the SIS domain "emotion," "strength," and "participation." Patients with NIHSS ≥1 had lower scores in all SIS domains except "emotions" and "mobility." Patients ≥50 years had lower score in "mobility" (p = 0.004) and females in domain of "social participation" (p = 0.044). No differences were found among all subgroups in HADS anxiety and depression. Age, NIHSS score, and depression were found negative predictors for the physical domains of HRQoL.

Discussion/conclusions: Despite excellent 3-month clinical outcome after IS, patients had affected substantially their HRQoL, especially those with NIHSS ≥1. Patients ≥50 years had more affected "mobility" and females "social participation."

背景和目的:缺血性脑卒中(IS)可能会影响长期健康相关生活质量(HRQoL),即使是临床预后良好的患者也不例外,而大多数用于评估预后的工具可能会低估或无法反映 IS 后的所有相关后果。我们的目的是分析 IS 后疗效极佳的患者的 HRQoL:我们分析了连续参加前瞻性 FRAILTY 研究(ClinicalTrials.gov:NCT04839887)的 IS 患者,这些患者的三个月临床疗效极佳(改良 Rankin 量表评分 0-1 分,mRS)。脑卒中影响量表(SIS)3.0版和医院焦虑抑郁量表(HADS)用于HRQoL、焦虑和抑郁评估,并根据NIHSS评分(0,≥1)、年龄(50 结果)进行亚组比较:共分析了 158 名患者(55.7% 为男性,平均年龄为 60.3 ± 13.4 岁),其中 72.2% 的患者 mRS 得分为 0。SIS "情感"、"力量 "和 "参与 "领域的中位数得分最低。NIHSS≥1 的患者除 "情绪 "和 "活动能力 "外,在所有 SIS 领域的得分都较低。年龄≥50 岁的患者在 "活动能力 "方面得分较低(P=0.004),女性在 "社会参与 "方面得分较低(P=0.044)。所有亚组在 HADS 焦虑和抑郁方面均无差异。年龄、NIHSS 评分和抑郁对 HRQoL 的生理领域具有负向预测作用:尽管IS术后三个月的临床疗效极佳,但患者的HRQoL受到了很大影响,尤其是NIHSS≥1的患者。年龄≥50岁的患者在 "行动能力 "和女性 "社会参与 "方面受到的影响更大。
{"title":"Quality of Life in Patients with Excellent 3-Month Clinical Outcome after First-Ever Ischemic Stroke: A Time to Redefine Excellent Outcome?","authors":"Daniel Šaňák, Elena Gurková, Lenka Štureková, Šárka Šaňáková, Jana Zapletalová, David Franc, Daniela Bartoníčková","doi":"10.1159/000535685","DOIUrl":"10.1159/000535685","url":null,"abstract":"<p><strong>Introduction: </strong>Ischemic stroke (IS) may have impact on long-term health-related quality of life (HRQoL) even in the patients with good clinical outcome, and tools mostly used for the assessment of outcome may underestimate or not reflect all relevant sequels after IS. We aimed to analyze HRQoL in the patients with excellent outcome after IS.</p><p><strong>Methods: </strong>We analyzed consecutive IS patients enrolled in the prospective FRAILTY study (ClinicalTrials.gov: NCT04839887) with excellent 3-month clinical outcome (score 0-1 in modified Rankin Scale [mRS]). Stroke Impact Scale (SIS) version 3.0 and Hospital Anxiety and Depression Scale (HADS) were used for the HRQoL, anxiety, and depression assessments, and subgroup comparisons were performed according to NIHSS score (0, ≥1), age (50&lt;, ≥50 years), and sex.</p><p><strong>Results: </strong>In total, 158 patients (55.7% men, mean age 60.3 ± 13.4 years) were analyzed, and 72.2% of them had score 0 in mRS. The overall lowest median scores were found in the SIS domain \"emotion,\" \"strength,\" and \"participation.\" Patients with NIHSS ≥1 had lower scores in all SIS domains except \"emotions\" and \"mobility.\" Patients ≥50 years had lower score in \"mobility\" (p = 0.004) and females in domain of \"social participation\" (p = 0.044). No differences were found among all subgroups in HADS anxiety and depression. Age, NIHSS score, and depression were found negative predictors for the physical domains of HRQoL.</p><p><strong>Discussion/conclusions: </strong>Despite excellent 3-month clinical outcome after IS, patients had affected substantially their HRQoL, especially those with NIHSS ≥1. Patients ≥50 years had more affected \"mobility\" and females \"social participation.\"</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"1-10"},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139485322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variations in Risk Factors across Different Periods of Stroke and Transient Ischemic Attack Recurrence. 中风和短暂性脑缺血发作复发不同时期风险因素的变化。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-07-27 DOI: 10.1159/000540571
Sang-Hun Lee, Jin-Man Jung, Jae-Chan Ryu, Moon-Ho Park

Introduction: Accurately discerning periods of heightened risk of stroke or transient ischemic attack (TIA) recurrence and managing modifiable risk factors are essential for minimizing overall recurrence risk. This study identified differences in the timing of stroke or TIA recurrence based on risk factors and patient characteristics to develop strategies for reducing recurrence in clinical practice.

Methods: We retrospectively selected patients with ischemic stroke or TIA at the Korea University Ansan Hospital Stroke Center between March 2014 and December 2021 using the prospective institutional database of the Korea University Stroke Registry. We collected demographic, clinical data, and categorized participants by recurrence timing (early within or late after 3 months). Using multinomial logistic regression analysis, we examined variables associated with early and late recurrent stroke or TIAs.

Results: Among 3,646 patients, 255 experienced a recurrent stroke or TIA and 3,391 experienced their first stroke or TIA. Multinomial logistic regression analysis revealed significant associations between early recurrent stroke or TIA and diabetes mellitus (odds ratio [OR]: 1.98, 95% confidence interval [CI]: 1.25-3.15), other determined etiologies in the Trial of Org 10172 in the Acute Stroke Treatment classification (OR: 3.00, 95% CI: 1.37-6.61), and white matter changes (OR: 1.97, 95% CI: 1.17-3.33). Late recurrence showed a significant correlation with TIA (OR: 2.95, 95% CI: 1.52-5.71) and cerebral microbleeds (OR: 2.22, 95% CI: 1.32-3.75).

Conclusion: Substantial differences in factors contribute to stroke or TIA recurrence based on timing. Managing the risk of recurrence in clinical practice necessitates accurate identification of heightened risk periods and rigorous control of modifiable risk factors.

导言:准确识别卒中或短暂性脑缺血发作(TIA)复发风险的高发期并管理可改变的风险因素对于最大限度地降低总体复发风险至关重要。本研究根据风险因素和患者特征确定了卒中或 TIA 复发时间的差异,以便在临床实践中制定减少复发的策略:方法:我们利用韩国大学卒中登记处的前瞻性机构数据库,回顾性地选择了 2014 年 3 月至 2021 年 12 月期间在韩国大学安山医院卒中中心就诊的缺血性卒中或 TIA 患者。我们收集了人口统计学和临床数据,并按复发时间(3 个月内早期或 3 个月后晚期)对参与者进行了分类。通过多项式逻辑回归分析,我们研究了与早期和晚期复发中风或 TIA 相关的变量:结果:在 3,646 名患者中,255 人复发了中风或 TIA,3,391 人首次出现中风或 TIA。多项式逻辑回归分析显示,早期复发性卒中或 TIA 与糖尿病(几率比 [OR] 1.98,95% 置信区间 [CI]1.25-3.15)、急性卒中治疗分类中 Org 10172 试验确定的其他病因(OR 3.00,95% CI 1.37-6.61)和白质改变(OR 1.97,95% CI 1.17-3.33)有显著相关性。晚期复发与TIA(OR 2.95,95% CI 1.52-5.71)和脑微出血(OR 2.22,95% CI 1.32-3.75)有显著相关性:结论:导致卒中或 TIA 复发的因素在时间上存在很大差异。在临床实践中管理复发风险需要准确识别高危时期并严格控制可改变的风险因素。
{"title":"Variations in Risk Factors across Different Periods of Stroke and Transient Ischemic Attack Recurrence.","authors":"Sang-Hun Lee, Jin-Man Jung, Jae-Chan Ryu, Moon-Ho Park","doi":"10.1159/000540571","DOIUrl":"10.1159/000540571","url":null,"abstract":"<p><strong>Introduction: </strong>Accurately discerning periods of heightened risk of stroke or transient ischemic attack (TIA) recurrence and managing modifiable risk factors are essential for minimizing overall recurrence risk. This study identified differences in the timing of stroke or TIA recurrence based on risk factors and patient characteristics to develop strategies for reducing recurrence in clinical practice.</p><p><strong>Methods: </strong>We retrospectively selected patients with ischemic stroke or TIA at the Korea University Ansan Hospital Stroke Center between March 2014 and December 2021 using the prospective institutional database of the Korea University Stroke Registry. We collected demographic, clinical data, and categorized participants by recurrence timing (early within or late after 3 months). Using multinomial logistic regression analysis, we examined variables associated with early and late recurrent stroke or TIAs.</p><p><strong>Results: </strong>Among 3,646 patients, 255 experienced a recurrent stroke or TIA and 3,391 experienced their first stroke or TIA. Multinomial logistic regression analysis revealed significant associations between early recurrent stroke or TIA and diabetes mellitus (odds ratio [OR]: 1.98, 95% confidence interval [CI]: 1.25-3.15), other determined etiologies in the Trial of Org 10172 in the Acute Stroke Treatment classification (OR: 3.00, 95% CI: 1.37-6.61), and white matter changes (OR: 1.97, 95% CI: 1.17-3.33). Late recurrence showed a significant correlation with TIA (OR: 2.95, 95% CI: 1.52-5.71) and cerebral microbleeds (OR: 2.22, 95% CI: 1.32-3.75).</p><p><strong>Conclusion: </strong>Substantial differences in factors contribute to stroke or TIA recurrence based on timing. Managing the risk of recurrence in clinical practice necessitates accurate identification of heightened risk periods and rigorous control of modifiable risk factors.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"213-222"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11651328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141787736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis. 滤泡 T 辅助细胞和 T 辅助细胞 17 相关分子对重症肌无力患者病情严重程度的影响
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-21 DOI: 10.1159/000540794
Doruk Arslan, Zeynep Ergul-Ulger, Sibel Goksen, Gunes Esendagli, Sevim Erdem-Ozdamar, Ersin Tan, Can Ebru Bekircan-Kurt

Introduction: Contribution of T helper 1 and 2 cells-related cytokines to pathogenesis of myasthenia gravis (MG) is well known. Recently, the contribution of follicular T helper (Tfh) and T helper 17 cells-related molecules to the pathogenesis has gained importance. In this study, we aimed to evaluate the changes in Tfh- and Th17-related molecules before and after rescue therapy in patients with myasthenic crisis (cMG) and to reveal the molecular differences between stable MG and cMG patients.

Methods: Patients with stable generalized MG (gMG) and cMG were classified according to Myasthenia Gravis Foundation of America (MGFA) classification. Serum samples were collected from cMG patients both before and after rescue therapy (plasmapheresis or intravenous immunoglobulin [IVIg]). Serum levels of Tfh- and selected Th17-related molecules (IL-22, IL-17A, CXCL13, sPD-L1, sICOSLG, and sCD40L) were analyzed by commercial ELISA kits.

Results: Twelve cMG (6 for IVIg, 6 for plasmapheresis) and 10 gMG patients were included in the study. A decrease in serum sPD-L1 and CXCL13 levels was observed in cMG patients after treatment, regardless of the treatment modality (p < 0.05). In contrast, serum sICOSLG levels decreased only in patients treated with IVIg (p < 0.05) and serum IL-22 levels increased in patients receiving plasmapheresis (p < 0.05). cMG patients had higher serum IL-17A levels compared to stable patients (p < 0.001) and its level was positively correlated with disease severity (r = 0.678, p = 0.001).

Conclusion: Our results confirm the contribution of Tfh- and Th17-related cell pathways to MG pathogenesis. Both IVIg and plasmapheresis appear to be effective in reducing Tfh- and Th17-related cytokine/molecule levels in cMG patients. Increased serum IL-17A levels may contribute to disease severity.

导言:与 T 辅助细胞 1 和 2 相关的细胞因子对重症肌无力(MG)发病机制的作用已众所周知。最近,滤泡T辅助细胞(Tfh)和T辅助细胞17相关分子对发病机制的贡献也变得越来越重要。在这项研究中,我们旨在评估肌无力危象(cMG)患者在抢救治疗前后Tfh和Th17相关分子的变化,并揭示稳定型MG和肌无力危象患者之间的分子差异:方法:根据美国肌无力基金会(MGFA)的分类方法对稳定型全身性肌无力(gMG)和肌无力危象(cMG)患者进行分类。在抢救治疗(血浆置换术或IVIg)之前和之后采集cMG患者的血清样本。)采用商业ELISA试剂盒分析血清中Tfh和选定的Th17相关分子(IL-22、IL-17A、CXCL13、sPD-L1、sICOSLG和sCD40L)的水平:研究共纳入了 12 名 cMG(6 名接受了 IVIg 治疗,6 名接受了血浆置换术)和 10 名 gMG 患者。无论采用哪种治疗方式,cMG 患者治疗后血清 sPDL1 和 CXCL13 水平均有所下降(p<0.05)。相比之下,只有接受 IVIg 治疗的患者血清 sICOSLG 水平下降(p<0.05),接受血浆置换治疗的患者血清 IL22 水平上升(p<0.05)。与病情稳定的患者相比,cMG 患者血清 IL-17A 水平较高(p<0.001),且其水平与病情严重程度呈正相关(r=0.678,p=0.001):我们的研究结果证实了Tfh和Th17相关细胞通路对MG发病机制的贡献。IVIg和血浆置换术似乎都能有效降低肌无力危象患者的Tfh和Th17相关细胞因子/分子水平。血清IL-17A水平的升高可能会导致疾病的严重程度。
{"title":"Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis.","authors":"Doruk Arslan, Zeynep Ergul-Ulger, Sibel Goksen, Gunes Esendagli, Sevim Erdem-Ozdamar, Ersin Tan, Can Ebru Bekircan-Kurt","doi":"10.1159/000540794","DOIUrl":"10.1159/000540794","url":null,"abstract":"<p><strong>Introduction: </strong>Contribution of T helper 1 and 2 cells-related cytokines to pathogenesis of myasthenia gravis (MG) is well known. Recently, the contribution of follicular T helper (Tfh) and T helper 17 cells-related molecules to the pathogenesis has gained importance. In this study, we aimed to evaluate the changes in Tfh- and Th17-related molecules before and after rescue therapy in patients with myasthenic crisis (cMG) and to reveal the molecular differences between stable MG and cMG patients.</p><p><strong>Methods: </strong>Patients with stable generalized MG (gMG) and cMG were classified according to Myasthenia Gravis Foundation of America (MGFA) classification. Serum samples were collected from cMG patients both before and after rescue therapy (plasmapheresis or intravenous immunoglobulin [IVIg]). Serum levels of Tfh- and selected Th17-related molecules (IL-22, IL-17A, CXCL13, sPD-L1, sICOSLG, and sCD40L) were analyzed by commercial ELISA kits.</p><p><strong>Results: </strong>Twelve cMG (6 for IVIg, 6 for plasmapheresis) and 10 gMG patients were included in the study. A decrease in serum sPD-L1 and CXCL13 levels was observed in cMG patients after treatment, regardless of the treatment modality (p < 0.05). In contrast, serum sICOSLG levels decreased only in patients treated with IVIg (p < 0.05) and serum IL-22 levels increased in patients receiving plasmapheresis (p < 0.05). cMG patients had higher serum IL-17A levels compared to stable patients (p < 0.001) and its level was positively correlated with disease severity (r = 0.678, p = 0.001).</p><p><strong>Conclusion: </strong>Our results confirm the contribution of Tfh- and Th17-related cell pathways to MG pathogenesis. Both IVIg and plasmapheresis appear to be effective in reducing Tfh- and Th17-related cytokine/molecule levels in cMG patients. Increased serum IL-17A levels may contribute to disease severity.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"223-229"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relevance of Continuous EEG versus Routine EEG for Outcome Prediction after Traumatic Brain Injury. 连续脑电图与常规脑电图对创伤性脑损伤后结果预测的相关性。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-09-13 DOI: 10.1159/000541335
Valentin Loser, Andrea O Rossetti, Marija Rasic, Jan Novy, Kaspar A Schindler, Stephan Rüegg, Vincent Alvarez, Isabelle Beuchat

Introduction: In a cohort of adult patients with disturbance of consciousness after TBI, we aimed to explore the relationship of continuous video-EEG (cEEG) versus routine EEG (rEEG) with mortality and functional outcome.

Methods: This is a post hoc analysis of a randomized controlled trial (CERTA), in which adults with disorder of consciousness and needing EEG (excluding those with proven seizures/SE just before) were randomized 1:1 to cEEG or two rEEG. In TBI patients, correlation between EEG duration, mortality, and modified Rankin score (mRs, good 0-2) at 6 months was assessed.

Results: Among 364 patients, 44 presenting with consciousness impairment after TBI were included; 29 randomized to cEEG and 15 to rEEG. Mortality (p = 0.88) and functional outcome (p = 0.58) at 6 months were similar between groups. There was a nonsignificant tendency toward more seizure/status epilepticus detection with cEEG (p = 0.08). In multivariable regression, cEEG was not related to functional outcome (OR: 0.75 [0.13-4.24], p = 0.745) or mortality (OR: 7.11 [0.51-99.32], p = 0.145).

Conclusion: Despite allowing increased seizure detections in TBI patients, cEEG does not seem to be associated with better functional outcome or mortality over rEEG. Pending larger trials, repeated rEEG might be acceptable in post-TBI disorder of consciousness, especially in resource-limited environments.

简介:在一组创伤后意识障碍的成年患者中,我们旨在探讨连续视频脑电图(cEEG)和常规脑电图(rEEG)与死亡率和功能预后的关系:对一项随机对照试验(CERTA 研究)的数据进行事后分析,在该试验中,需要进行脑电图检查的意识障碍成人被按 1:1 随机分配到 cEEG 或两个 rEEG。在创伤性脑损伤患者中,评估了脑电图持续时间与死亡率和 6 个月时修正的兰金评分(mRs,良好 0-2)之间的相关性:在 364 名患者中,有 44 名患者在 TBI 后出现意识障碍,其中 29 人随机接受了 cEEG,15 人接受了 rEEG。两组患者 6 个月后的死亡率(P=0.88)和功能预后(P=0.58)相似。cEEG 可检测到更多的癫痫发作/癫痫状态(p=0.08),但这一趋势并不明显。在多变量回归中,cEEG 与功能预后(OR 0.75 [0.13-4.24],P=0.745)或死亡率(OR 7.11 [0.51-99.32],P=0.145)无关:结论:尽管 cEEG 可以增加对创伤性脑损伤患者癫痫发作的检测,但与 rEEG 相比,cEEG 似乎与更好的临床功能预后或死亡率无关。在进行更大规模的试验之前,对于创伤后意识障碍,尤其是在资源有限的环境中,重复使用 rEEG 也许是可以接受的。
{"title":"Relevance of Continuous EEG versus Routine EEG for Outcome Prediction after Traumatic Brain Injury.","authors":"Valentin Loser, Andrea O Rossetti, Marija Rasic, Jan Novy, Kaspar A Schindler, Stephan Rüegg, Vincent Alvarez, Isabelle Beuchat","doi":"10.1159/000541335","DOIUrl":"10.1159/000541335","url":null,"abstract":"<p><strong>Introduction: </strong>In a cohort of adult patients with disturbance of consciousness after TBI, we aimed to explore the relationship of continuous video-EEG (cEEG) versus routine EEG (rEEG) with mortality and functional outcome.</p><p><strong>Methods: </strong>This is a post hoc analysis of a randomized controlled trial (CERTA), in which adults with disorder of consciousness and needing EEG (excluding those with proven seizures/SE just before) were randomized 1:1 to cEEG or two rEEG. In TBI patients, correlation between EEG duration, mortality, and modified Rankin score (mRs, good 0-2) at 6 months was assessed.</p><p><strong>Results: </strong>Among 364 patients, 44 presenting with consciousness impairment after TBI were included; 29 randomized to cEEG and 15 to rEEG. Mortality (p = 0.88) and functional outcome (p = 0.58) at 6 months were similar between groups. There was a nonsignificant tendency toward more seizure/status epilepticus detection with cEEG (p = 0.08). In multivariable regression, cEEG was not related to functional outcome (OR: 0.75 [0.13-4.24], p = 0.745) or mortality (OR: 7.11 [0.51-99.32], p = 0.145).</p><p><strong>Conclusion: </strong>Despite allowing increased seizure detections in TBI patients, cEEG does not seem to be associated with better functional outcome or mortality over rEEG. Pending larger trials, repeated rEEG might be acceptable in post-TBI disorder of consciousness, especially in resource-limited environments.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"306-311"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Cerebellar Repetitive Transcranial Magnetic Stimulation in the Treatment of Post-Stroke Dysphagia: A Meta-Analysis and Systematic Review of Randomized Controlled Trials. 小脑重复经颅磁刺激治疗中风后吞咽困难的效果:随机对照试验的荟萃分析和系统回顾。
IF 2.4 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-03-02 DOI: 10.1159/000538130
Ying Liu, Shao Yin, Xinwei Yang, Shanshan Luo, Fengya Zhu, Zijian Zeng, Qian Hu, Li Xu, Qian Yu

Introduction: This study aimed to comprehensively evaluate the therapeutic efficacy of cerebellar repetitive transcranial magnetic stimulation (rTMS) in the rehabilitation of post-stroke dysphagia (PSD).

Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we systematically searched PubMed, Cochrane Library, Embase, and Web of Science to identify relevant randomized controlled trials (RCTs) investigating the application of cerebellar rTMS in the treatment of PSD. Inclusion and exclusion criteria were rigorously applied during the screening process, and pertinent characteristics of the included RCTs were meticulously extracted. The I2 statistic was employed to assess heterogeneity, and meta-analysis was conducted using Stata 17 software. The Cochrane Risk of Bias 2 tool and PEDro scale were utilized to evaluate bias risk and literature quality.

Results: Our analysis encompassed a total of 5 RCTs involving 673 patients with dysphagia who met the inclusion criteria. The findings indicated a significant positive impact of cerebellar rTMS when combined with traditional swallowing exercises on PSD, demonstrating superior efficacy compared to conventional swallowing exercises in isolation. Furthermore, the study revealed no statistically significant differences based on stimulation site (unilateral vs. bilateral cerebellum), stimulation mode (rTMS vs. intermittent theta-burst stimulation), and stimulation frequency (5 Hz vs. 10 Hz).

Conclusion: The amalgamation of cerebellar rTMS with conventional swallowing exercises demonstrates notable efficacy, surpassing the outcomes achievable with traditional exercises alone. The sustained effectiveness observed underscores the potential of cerebellar rTMS as an innovative avenue in the field of neurorehabilitation for PSD. This study contributes valuable insights into the prospect of utilizing cerebellar rTMS as an adjunctive therapeutic strategy in the management of PSD, emphasizing its relevance for further exploration and clinical application.

导言:本研究旨在全面评估小脑重复经颅磁刺激(rTMS)在卒中后吞咽困难(PSD)康复中的疗效。研究方法根据系统综述和荟萃分析首选报告项目(PRISMA)指南,我们系统地检索了 PubMed、Cochrane Library、Embase 和 Web of Science,以确定研究小脑经颅磁刺激治疗 PSD 的相关随机对照试验(RCT)。筛选过程中严格执行了纳入和排除标准,并仔细提取了纳入的 RCT 的相关特征。采用I2统计量评估异质性,并使用Stata 17软件进行荟萃分析。采用 Cochrane Risk of Bias 2 工具和 Pedro 量表评估偏倚风险和文献质量。结果我们的分析共包括 5 项 RCT,涉及 673 名符合纳入标准的吞咽困难患者。研究结果表明,小脑经颅磁刺激与传统吞咽练习相结合对 PSD 有明显的积极影响,与单独的传统吞咽练习相比,疗效更佳。此外,研究还发现,刺激部位(单侧小脑与双侧小脑)、刺激模式(经频磁刺激与间歇性θ-脉冲刺激[iTBS])和刺激频率(5Hz与10Hz)在统计学上没有显著差异。
{"title":"Effects of Cerebellar Repetitive Transcranial Magnetic Stimulation in the Treatment of Post-Stroke Dysphagia: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.","authors":"Ying Liu, Shao Yin, Xinwei Yang, Shanshan Luo, Fengya Zhu, Zijian Zeng, Qian Hu, Li Xu, Qian Yu","doi":"10.1159/000538130","DOIUrl":"10.1159/000538130","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to comprehensively evaluate the therapeutic efficacy of cerebellar repetitive transcranial magnetic stimulation (rTMS) in the rehabilitation of post-stroke dysphagia (PSD).</p><p><strong>Methods: </strong>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we systematically searched PubMed, Cochrane Library, Embase, and Web of Science to identify relevant randomized controlled trials (RCTs) investigating the application of cerebellar rTMS in the treatment of PSD. Inclusion and exclusion criteria were rigorously applied during the screening process, and pertinent characteristics of the included RCTs were meticulously extracted. The I2 statistic was employed to assess heterogeneity, and meta-analysis was conducted using Stata 17 software. The Cochrane Risk of Bias 2 tool and PEDro scale were utilized to evaluate bias risk and literature quality.</p><p><strong>Results: </strong>Our analysis encompassed a total of 5 RCTs involving 673 patients with dysphagia who met the inclusion criteria. The findings indicated a significant positive impact of cerebellar rTMS when combined with traditional swallowing exercises on PSD, demonstrating superior efficacy compared to conventional swallowing exercises in isolation. Furthermore, the study revealed no statistically significant differences based on stimulation site (unilateral vs. bilateral cerebellum), stimulation mode (rTMS vs. intermittent theta-burst stimulation), and stimulation frequency (5 Hz vs. 10 Hz).</p><p><strong>Conclusion: </strong>The amalgamation of cerebellar rTMS with conventional swallowing exercises demonstrates notable efficacy, surpassing the outcomes achievable with traditional exercises alone. The sustained effectiveness observed underscores the potential of cerebellar rTMS as an innovative avenue in the field of neurorehabilitation for PSD. This study contributes valuable insights into the prospect of utilizing cerebellar rTMS as an adjunctive therapeutic strategy in the management of PSD, emphasizing its relevance for further exploration and clinical application.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"67-78"},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140021281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ego- and Geo-Centered References: A Functional Neuroimagery Study. 以自我和地理为中心的参照:功能神经图像研究。
IF 2.4 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-01-16 DOI: 10.1159/000535725
Arnaud Saj, Jacques Honoré, Liliane Borel

Introduction: The integration of vestibular, visual, and somatosensory cues allows the perception of space through the orientation of our body and surrounding objects with respect to gravity. The main goal of this study was to identify the cortical networks recruited during the representation of body midline and the representation of verticality.

Methods: Thirty right-handed healthy participants were evaluated using fMRI. Brain networks activated during a subjective straight-ahead (SSA) task were compared to those recruited during a subjective vertical (SV) task.

Results: Different patterns of cortical activation were observed, with differential increases in the angular gyrus and left cerebellum posterior lobe during the SSA task, in right rolandic operculum and cerebellum anterior lobe during the SV task.

Discussion: The activation of these areas involved in visuo-spatial functions suggests that bodily processes of great complexity are engaged in body representation and vertical perception. Interestingly, the common brain networks involved in SSA and SV tasks were comprised of areas of vestibular projection that receive multisensory information (parieto-occipital areas) and the cerebellum, and reveal a predominance of the right cerebral and cerebellar hemispheres. The outcomes of this first fMRI study designed to unmask common and specific neural mechanisms at work in gravity- or body-referenced tasks pave a new way for the exploration of spatial cognitive impairment in patients with vestibular or cortical disorders.

导言--前庭、视觉和体感线索的整合使我们能够通过身体和周围物体相对于重力的方位来感知空间。本研究的主要目的是确定在表征身体中线和表征垂直度时所招募的大脑皮层网络。方法 - 使用 fMRI 对 30 名右手健康的参与者进行评估。将主观直向(SSA)任务中激活的大脑网络与主观垂直(SV)任务中招募的大脑网络进行比较。结果 - 观察到不同的大脑皮层激活模式,SSA 任务中角回和左侧小脑后叶的激活程度不同,SV 任务中右侧蝶鞍和小脑前叶的激活程度不同。这些与视觉空间功能有关的区域被激活表明,身体表征和垂直感知过程非常复杂。讨论 - 有趣的是,参与 SSA 和 SV 任务的共同脑网络是接收多感官信息的前庭投射区(顶枕区)和小脑,并显示右侧大脑和小脑半球占主导地位。这项首次旨在揭示重力或身体参照任务中常见和特定神经机制的 fMRI 研究结果,为探索前庭或皮质疾病患者的空间认知障碍铺平了新的道路。
{"title":"Ego- and Geo-Centered References: A Functional Neuroimagery Study.","authors":"Arnaud Saj, Jacques Honoré, Liliane Borel","doi":"10.1159/000535725","DOIUrl":"10.1159/000535725","url":null,"abstract":"<p><strong>Introduction: </strong>The integration of vestibular, visual, and somatosensory cues allows the perception of space through the orientation of our body and surrounding objects with respect to gravity. The main goal of this study was to identify the cortical networks recruited during the representation of body midline and the representation of verticality.</p><p><strong>Methods: </strong>Thirty right-handed healthy participants were evaluated using fMRI. Brain networks activated during a subjective straight-ahead (SSA) task were compared to those recruited during a subjective vertical (SV) task.</p><p><strong>Results: </strong>Different patterns of cortical activation were observed, with differential increases in the angular gyrus and left cerebellum posterior lobe during the SSA task, in right rolandic operculum and cerebellum anterior lobe during the SV task.</p><p><strong>Discussion: </strong>The activation of these areas involved in visuo-spatial functions suggests that bodily processes of great complexity are engaged in body representation and vertical perception. Interestingly, the common brain networks involved in SSA and SV tasks were comprised of areas of vestibular projection that receive multisensory information (parieto-occipital areas) and the cerebellum, and reveal a predominance of the right cerebral and cerebellar hemispheres. The outcomes of this first fMRI study designed to unmask common and specific neural mechanisms at work in gravity- or body-referenced tasks pave a new way for the exploration of spatial cognitive impairment in patients with vestibular or cortical disorders.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"36-42"},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139477534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Everyday Memory Disturbance in Primary Progressive Aphasia. 原发性进行性失语症的日常记忆障碍。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-16 DOI: 10.1159/000540340
David Foxe, Gyan Ainkaran, James Carrick, Sau Chi Cheung, Rebekah M Ahmed, Manisha Narasimhan, James R Burrell, Yun Tae Hwang, Muireann Irish, Olivier Piguet

Introduction: Mounting evidence indicates distinct memory profiles among the primary progressive aphasia (PPA) variants. Neuropsychological tests reveal disproportionate memory impairments in the logopenic variant PPA (lv-PPA) relative to the non-fluent variant PPA (nfv-PPA) and semantic variant PPA (sv-PPA). The real-world experience of day-to-day memory disturbances in PPA, however, remains poorly understood.

Methods: Everyday expressions of memory in 26 lv-PPA, 24 nfv-PPA, and 40 sv-PPA patients, and 70 healthy controls were examined using the Cambridge Behavioural Inventory-Revised (CBI-R) carer questionnaire. Kruskal-Wallis tests compared CBI-R Memory items (1-8) across groups. Receiver operating characteristic curves evaluated the most discriminative items to distinguish lv-PPA from nfv-PPA.

Results: Compared to controls, lv-PPA and sv-PPA patients were reported to experience more day-to-day memory issues (item 1), increased repetition of questions (2), forgetting the names of familiar people and objects (4, 5), and poor concentration (6). lv-PPA patients were also reported to exhibit more occurrences of losing or misplacing items (3) and forgetting the day (7). All PPA groups experienced more confusion in unfamiliar environments (8) than controls. Direct comparisons among PPA groups revealed distinct profiles, with lv-PPA and sv-PPA patients exhibiting more frequent forgetting of names and objects (3, 4) than nfv-PPA, and sv-PPA demonstrating greater day-to-day memory impairment (1), repeated questions (2), and poor concentration (6) compared to nfv-PPA. Forgetting the names of familiar objects (5) was the most sensitive and specific item to distinguish lv-PPA from nfv-PPA.

Conclusions: Our findings demonstrate distinct day-to-day memory profiles in PPA. Future research should explore the influence of language impairments on these profiles.

简介越来越多的证据表明,原发性进行性失语症(PPA)变体之间存在不同的记忆特征。神经心理学测试显示,相对于非流利型(nfv-PPA)和语义型(sv-PPA)变体,对数开放型变体(lv-PPA)的记忆障碍不成比例。然而,人们对 PPA 患者日常记忆障碍的真实体验仍然知之甚少:方法:使用《剑桥行为清单-修订版》(CBI-R)照护者问卷调查了 26 名语义型 PPA、24 名非语义型 PPA 和 40 名语义型 PPA 患者以及 70 名健康对照者的日常记忆表达。Kruskal-Wallis 检验比较了各组的 CBI-R 记忆项目(1-8)。接收者操作特征曲线评估了区分lv-PPA和nfv-PPA的最具区分性的项目:结果:与对照组相比,lv-PPA 和 sv-PPA 患者被报告有更多的日常记忆问题(第 1 项)、重复问题增多(第 2 项)、忘记熟悉的人和物的名称(第 4、5 项)以及注意力不集中(第 6 项)。据报告,Lv-PPA 患者还表现出更多丢失或放错物品(3)和忘记日期(7)的情况。与对照组相比,所有 PPA 组患者在陌生环境中都更容易感到困惑(8)。PPA 各组之间的直接比较显示出不同的特征,与 nfv-PPA 相比,lv-PPA 和 sv-PPA 患者遗忘姓名和物品的频率更高(3,4),而与 nfv-PPA 相比,sv-PPA 表现出更严重的日常记忆障碍(1)、重复问题(2)和注意力不集中(6)。忘记熟悉物体的名称(5)是区分lv-PPA和nfv-PPA最敏感、最特异的项目:我们的研究结果表明,PPA 患者的日常记忆特征各不相同。未来的研究应探讨语言障碍对这些特征的影响。
{"title":"Everyday Memory Disturbance in Primary Progressive Aphasia.","authors":"David Foxe, Gyan Ainkaran, James Carrick, Sau Chi Cheung, Rebekah M Ahmed, Manisha Narasimhan, James R Burrell, Yun Tae Hwang, Muireann Irish, Olivier Piguet","doi":"10.1159/000540340","DOIUrl":"10.1159/000540340","url":null,"abstract":"<p><strong>Introduction: </strong>Mounting evidence indicates distinct memory profiles among the primary progressive aphasia (PPA) variants. Neuropsychological tests reveal disproportionate memory impairments in the logopenic variant PPA (lv-PPA) relative to the non-fluent variant PPA (nfv-PPA) and semantic variant PPA (sv-PPA). The real-world experience of day-to-day memory disturbances in PPA, however, remains poorly understood.</p><p><strong>Methods: </strong>Everyday expressions of memory in 26 lv-PPA, 24 nfv-PPA, and 40 sv-PPA patients, and 70 healthy controls were examined using the Cambridge Behavioural Inventory-Revised (CBI-R) carer questionnaire. Kruskal-Wallis tests compared CBI-R Memory items (1-8) across groups. Receiver operating characteristic curves evaluated the most discriminative items to distinguish lv-PPA from nfv-PPA.</p><p><strong>Results: </strong>Compared to controls, lv-PPA and sv-PPA patients were reported to experience more day-to-day memory issues (item 1), increased repetition of questions (2), forgetting the names of familiar people and objects (4, 5), and poor concentration (6). lv-PPA patients were also reported to exhibit more occurrences of losing or misplacing items (3) and forgetting the day (7). All PPA groups experienced more confusion in unfamiliar environments (8) than controls. Direct comparisons among PPA groups revealed distinct profiles, with lv-PPA and sv-PPA patients exhibiting more frequent forgetting of names and objects (3, 4) than nfv-PPA, and sv-PPA demonstrating greater day-to-day memory impairment (1), repeated questions (2), and poor concentration (6) compared to nfv-PPA. Forgetting the names of familiar objects (5) was the most sensitive and specific item to distinguish lv-PPA from nfv-PPA.</p><p><strong>Conclusions: </strong>Our findings demonstrate distinct day-to-day memory profiles in PPA. Future research should explore the influence of language impairments on these profiles.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"177-187"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141999644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 Pandemic on Acute Stroke Rehabilitation in Japanese Primary Stroke Centers: A Nationwide Cross-Sectional Study Using a Web-Based Questionnaire Survey. COVID-19 大流行对日本初级卒中中心急性卒中康复的影响:利用网络问卷调查进行的全国横断面研究。
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-01-01 Epub Date: 2024-07-31 DOI: 10.1159/000540231
Naoki Oyama, Koichi Oki, Makoto Nakajima, Koichi Matsumoto, Tomohiro Omori, Makoto Hayase, Tsuyoshi Ohta, Masatoshi Koga, Tetsuo Koyama, Shigeru Fujimoto, Yasuyuki Iguchi, Wataru Kakuda, Kuniaki Ogasawara

Introduction: Acute stroke rehabilitation is crucial for achieving good functional recovery, even during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to clarify the impact of the COVID-19 pandemic on acute stroke rehabilitation and identify which components in the acute stroke rehabilitation provision system were susceptible to the pandemic.

Methods: A web-based questionnaire survey was conducted in all primary stroke centers (PSCs) in Japan between February 7 and April 21, 2022. The survey included questions about the current status of acute stroke rehabilitation and the influence of the pandemic. We classified the influences and investigated the relationship between the influence of the pandemic and the provision of rehabilitation. Additionally, we investigated a group of prefectures divided according to the grade of the pandemic.

Results: The survey response rate was 67% (639 of 959 PSCs). Among them, 387 PSCs (61%) reported that the COVID-19 pandemic affected acute stroke rehabilitation. In PSCs affected by the pandemic, more rehabilitation-related staff were working, and the proportion of weekend/holiday rehabilitation implementation was higher compared to those unaffected. In PSCs from highly infected prefectures, no significant relationship was observed between the influence of the pandemic and the rehabilitation provision system.

Conclusions: PSCs that provide denser acute stroke rehabilitation may be affected to a greater extent by the pandemic. We conclude that stroke hospitals should formulate infection control procedures for acute stroke rehabilitation in advance, depending on the conditions of the region and facility.

导言:即使在冠状病毒病 2019(COVID-19)大流行期间,急性中风康复对于实现良好的功能恢复也至关重要。本研究旨在阐明 COVID-19 大流行对急性脑卒中康复的影响,并确定急性脑卒中康复服务体系中哪些部分易受大流行影响:方法:2022 年 2 月 7 日至 4 月 21 日期间,对日本所有初级卒中中心(PSC)进行了网络问卷调查。调查内容包括急性卒中康复的现状和大流行的影响。我们对影响因素进行了分类,并调查了大流行的影响与提供康复服务之间的关系。此外,我们还根据大流行的等级对一组都道府县进行了调查:调查回复率为 67%(959 个私营服务中心中的 639 个)。其中,387 家 PSC(61%)报告 COVID-19 大流行影响了急性卒中康复。与未受影响的康复中心相比,受大流行影响的康复中心有更多的康复相关人员在工作,周末/节假日康复实施的比例也更高。在疫情严重的县的初级保健中心,疫情影响与康复服务体系之间没有明显的关系:结论:提供较密集急性卒中康复服务的初级保健中心受大流行病的影响可能更大。我们的结论是,脑卒中医院应根据地区和设施条件,提前制定急性脑卒中康复的感染 控制程序。
{"title":"Impact of the COVID-19 Pandemic on Acute Stroke Rehabilitation in Japanese Primary Stroke Centers: A Nationwide Cross-Sectional Study Using a Web-Based Questionnaire Survey.","authors":"Naoki Oyama, Koichi Oki, Makoto Nakajima, Koichi Matsumoto, Tomohiro Omori, Makoto Hayase, Tsuyoshi Ohta, Masatoshi Koga, Tetsuo Koyama, Shigeru Fujimoto, Yasuyuki Iguchi, Wataru Kakuda, Kuniaki Ogasawara","doi":"10.1159/000540231","DOIUrl":"10.1159/000540231","url":null,"abstract":"<p><strong>Introduction: </strong>Acute stroke rehabilitation is crucial for achieving good functional recovery, even during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to clarify the impact of the COVID-19 pandemic on acute stroke rehabilitation and identify which components in the acute stroke rehabilitation provision system were susceptible to the pandemic.</p><p><strong>Methods: </strong>A web-based questionnaire survey was conducted in all primary stroke centers (PSCs) in Japan between February 7 and April 21, 2022. The survey included questions about the current status of acute stroke rehabilitation and the influence of the pandemic. We classified the influences and investigated the relationship between the influence of the pandemic and the provision of rehabilitation. Additionally, we investigated a group of prefectures divided according to the grade of the pandemic.</p><p><strong>Results: </strong>The survey response rate was 67% (639 of 959 PSCs). Among them, 387 PSCs (61%) reported that the COVID-19 pandemic affected acute stroke rehabilitation. In PSCs affected by the pandemic, more rehabilitation-related staff were working, and the proportion of weekend/holiday rehabilitation implementation was higher compared to those unaffected. In PSCs from highly infected prefectures, no significant relationship was observed between the influence of the pandemic and the rehabilitation provision system.</p><p><strong>Conclusions: </strong>PSCs that provide denser acute stroke rehabilitation may be affected to a greater extent by the pandemic. We conclude that stroke hospitals should formulate infection control procedures for acute stroke rehabilitation in advance, depending on the conditions of the region and facility.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":" ","pages":"169-176"},"PeriodicalIF":2.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141859436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Neurology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1